Domingo-Arrué B, Gil-Benso R, Megías J, Navarro L, San-Miguel T, Muñoz-Hidalgo L, López-Ginés C, Cerdá-Nicolás M
Department of Pathology, Universitat de València, and.
incliva, Clinic Hospital of Valencia, Valencia, Spain.
Curr Oncol. 2017 Jun;24(3):e244-e250. doi: 10.3747/co.24.3509. Epub 2017 Jun 27.
We report a case of a recurrent clear cell meningioma (ccm) in the frontal lobe of the brain of a 67-year-old man. The patient developed three recurrences: at 3, 10, and 12 years after his initial surgery. Histopathology observations revealed a grade 2 ccm with positivity for vimentin and epithelial membrane antigen. Expression of E-cadherin was positive only in the primary tumour and in the first available recurrence. Fluorescence hybridization analyses demonstrated 1p and 14q deletions within the last recurrence. Multiplex ligation-dependent probe amplification studies revealed a heterozygous partial gene deletion, which progressed to total loss in the last recurrence. The last recurrence showed homozygous deletions in and . The gene was hypermethylated during tumour evolution. In this report, we show the genetic alterations of a primary ccm and its recurrences to elucidate their relationships with the changes involved in the progression of this rare neoplasm.
我们报告了一例67岁男性大脑额叶复发性透明细胞脑膜瘤(ccm)的病例。该患者出现了三次复发:分别在初次手术后3年、10年和12年。组织病理学观察显示为2级ccm,波形蛋白和上皮膜抗原呈阳性。E-钙黏蛋白的表达仅在原发性肿瘤和首次复发时呈阳性。荧光杂交分析显示在最后一次复发时存在1p和14q缺失。多重连接依赖探针扩增研究揭示了一个杂合性部分基因缺失,该缺失在最后一次复发时进展为完全缺失。最后一次复发显示在[具体基因名称1]和[具体基因名称2]中存在纯合缺失。[具体基因名称]基因在肿瘤进展过程中发生了高甲基化。在本报告中,我们展示了原发性ccm及其复发的基因改变,以阐明它们与这种罕见肿瘤进展过程中所涉及变化的关系。